Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HB eAg seroconversion-Reference-Cited by-同舟云学术

Sustained off‐treatment viral control is associated with high hepatitis B surface antigen seroclearance rates in Caucasian patients with nucleos(t)ide analogue–induced HB eAg seroconversion

Published:2019-03-14 Issue:6 Volume:26 Page:766-769
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Van Hees Stijn¹²^ORCID,Chi Heng³^ORCID,Hansen Bettina³⁴,Bourgeois Stefan¹⁵,Van Vlierberghe Hans⁶,Sersté Thomas⁷,Francque Sven¹²,Wong David⁴,Sprengers Dirk⁸,Moreno Christophe⁹,Nevens Frederik¹⁰,Janssen Harry L. A.³⁴,Vanwolleghem Thomas¹²³^ORCID

Affiliation:

1. Department of Gastroenterology and HepatologyAntwerp University Hospital Antwerp Belgium

2. Laboratory of Experimental Medicine and PediatricsAntwerp University Antwerp Belgium

3. Department of Gastroenterology and HepatologyErasmus MC University Medical Center Rotterdam Rotterdam the Netherlands

4. Toronto Centre of Liver DiseaseUniversity Health NetworkToronto General HospitalUniversity of Toronto Toronto ON Canada

5. Department of Gastroenterology and HepatologyZNA Stuivenberg Antwerp Belgium

6. Department of Gastroenterology and HepatologyGhent University Hospital Ghent Belgium

7. Department of Gastroenterology and HepatologySaint‐Pierre University Hospital Brussels Belgium

8. Department of Gastroenterology and HepatologyGZA Antwerp Antwerp Belgium

9. Department of Gastroenterology, Hepatopancreatology and Digestive OncologyCUB Hôpital ErasmeUniversité Libre de Bruxelles Brussels Belgium

10. Department of HepatologyUniversity Hospitals KULeuven Leuven Belgium

Funder

Foundation Against Cancer Belgium

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13084

Reference8 articles.

1. Hepatitis B virus infection

2. Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

3. Sustained Responses and Loss of HBsAg in HBeAg-Negative Patients With Chronic Hepatitis B Who Stop Long-Term Treatment With Adefovir

4. Stopping long-term treatment with nucleos(t)ide analogues is a favourable option for selected patients with HBeAg-negative chronic hepatitis B

5. Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lower end of treatment HBsAg and HBcrAg were associated with HBsAg loss after nucleos(t)ide analog cessation;BMC Gastroenterology;2023-06-29

2. HBsAg ≤ 135 IU/mL or HBcrAg ≤ 3.6 logU/mL was associated with HBsAg loss after nucleos(t)ide analogue cessation;2023-03-09

3. IP10 and Anti-HBc can Predict Virological Relapse and HBsAg Loss in Chronic Hepatitis B Patients after Nucleos(t)ide Analog Discontinuation;Digestive Diseases;2023

4. Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B;International Journal of General Medicine;2021-08

5. High Rate of Virologic Response After Discontinuation of Nucleos(T)Ide Analogues in Caucasian Chronic Hepatitis B Patients;Clinical Gastroenterology and Hepatology;2021-02